Check Point (CHKP) Q3 2026 Earnings Call Transcript

Check Point reported Q3 revenue of $670 million, down 1% year over year as lower firewall refresh activity weighed on product and related revenues; subscription revenue rose 11% to $339 million, while non-GAAP EPS of $2.49 and adjusted free cash flow of $258 million exceeded the midpoint of company projections. Management said Q3 marked the product-revenue trough but described recovery as more gradual than previously expected; Q4 revenue guidance is $720 million–$770 million, with flat year-over-year growth at the midpoint. Growth-technology ARR rose more than 38%, while management cited $30 million of year-to-date currency headwinds and estimated up to $50 million of incremental operating-expense headwinds in 2027 at current exchange rates.

Analysis

CHKP’s key debate is not whether cybersecurity demand is growing, but whether its sales reset can convert new-product interest into durable, incremental customer wins before the firewall refresh cycle normalizes. The >38% growth in newer technology ARR is encouraging, but it does not yet offset the exposure of maintenance and attached subscriptions to deferred appliance refreshes. Large deals slipping into 2027 also make management’s “trough” call a timing thesis, not evidence that the recovery is secured. Q4 flat revenue at the midpoint and softer subscription growth leave little room for execution misses.

The bullish second-order case is that sovereign/private deployments and AI data-center traffic could support appliance demand even as conventional enterprise refreshes remain delayed. But this is a multi-quarter conversion opportunity: AI infrastructure spend does not automatically translate into CHKP security bookings, and the new sales force must prove it can open new logos. Price increases may protect economics against memory inflation, yet could also extend refresh deferrals; management’s own historical capture has been materially below the announced increase. FTNT is exposed to the same hardware-pricing environment, limiting the value of treating pricing as a CHKP-specific advantage.

Near term, currency and memory costs pressure margins; the Israeli-shekel exposure compounds in 2027. R&D grants and buybacks support reported earnings/capital returns but do not resolve operating leverage or product demand. The contrarian risk is that investors capitalize AI/CTEM growth as a platform inflection before billings and new-logo evidence confirm it. February’s strategy update and Q4-to-H1 subscription/billing trajectory are the key tests.

Key Decisions for Investors

• No immediate directional CHKP trade: wait for Q4 results and February strategy disclosures to validate that refresh activity, new-logo conversion, and subscription billings are improving together. Avoid treating management’s trough language as confirmation by itself.
• Watch for a conditional long CHKP only if product revenue stabilizes without a further deterioration in calculated billings, while newer-technology growth remains strong. Falsify the setup if refresh projects continue slipping, subscription growth decelerates further, or guidance fails to support the stated 2027 subscription target.
• Track CHKP gross margin and operating expense guidance against memory costs and shekel FX; a larger-than-expected margin decline would weaken the earnings case even if revenue stabilizes. Verify how much of the announced firewall price increase is realized and whether renewal or refresh timing worsens.
• Do not use FTNT as an automatic short hedge: both vendors face hardware cost and pricing dynamics, and the supplied evidence does not establish relative valuation or share-gain prospects. Reassess the pair only with comparative bookings, renewal, and margin data.